I
107TH CONGRESS
1ST SESSION
H. R. 326
To amend the Public Health Service Act to provide for programs regarding
ovarian cancer.
IN THE HOUSE OF REPRESENTATIVES
JANUARY 31, 2001
Mrs. MINK of Hawaii (for herself, Mrs. MORELLA, Mr. HILLIARD, Mr. HIN-
CHEY, Mr. WYNN, Ms. BALDWIN, Mr. CAPUANO, Mr. SANDERS, Ms.
PELOSI, Mr. ABERCROMBIE, Ms. MILLENDER-MCDONALD, Mr. GEORGE
MILLER of California, Mr. CUMMINGS, Mr. FALEOMAVAEGA, Mr. CROW-
LEY, Ms. JACKSON-LEE of Texas, Mr. WEINER, Ms. HOOLEY of Oregon,
Mr. MCNULTY, Ms. WATERS, Mrs. JONES of Ohio, Ms. MCKINNEY, Ms.
MCCARTHY of Missouri, Mrs. MALONEY of New York, Mr. FILNER, Mr.
WAXMAN, Mr. JEFFERSON, Ms. KAPTUR, Mr. RANGEL, Mrs. CAPPS, Mr.
SANDLIN, Ms. EDDIE BERNICE JOHNSON of Texas, Mr. LEVIN, Ms.
SCHAKOWSKY, Mr. LIPINSKI, Mrs. MEEK of Florida, Ms. WOOLSEY, Mr.
OWENS, Ms. BERKLEY, Mr. DAVIS
of Illinois, Mrs. LOWEY, Ms.
DELAURO, Mrs. THURMAN, Mr. MICA, Mr. GONZALEZ, Ms. NORTON, Mr.
BONIOR, Ms. RIVERS, Ms. KILPATRICK, Ms. BROWN of Florida, Ms. ROY-
BAL-ALLARD, Mr. MASCARA, Mr. WU, Ms. LEE, Mr. FROST, Mrs.
NAPOLITANO, and Ms. ESHOO) introduced the following bill; which was
referred to the Committee on Energy and Commerce
A BILL
To amend the Public Health Service Act to provide for
programs regarding ovarian cancer.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Ovarian Cancer
Research and Information Amendments of 2001’’.
SEC. 2. RESEARCH ON OVARIAN CANCER.
Section 417B(b)(2) of the Public Health Service Act
is amended—
(1) by striking ‘‘CANCERS.—For the purpose
of’’ and all that follows through ‘‘417,’’ and insert-
ing the following: ‘‘CANCERS.—
‘‘(A) For the purpose of carrying out sec-
tion 417(d),’’; and
(2) by adding at the end the following subpara-
graph:
‘‘(B)(i) For the purpose of carrying out re-
search under section 417(d) on ovarian cancer,
there 
are 
authorized 
to 
be 
appropriated
$150,000,000 for fiscal year 2002, and such
sums as may be necessary for each of the fiscal
years 2003 and 2004. With respect to such pur-
pose, such authorizations of appropriations are
in addition to the authorizations of appropria-
tions established in subparagraph (A) and in
subsection (a).
‘‘(ii) Of the amounts appropriated under
clause (i) for a fiscal year, the Director of the
Institute shall reserve 50 percent for research
described in such clause that does not involve
treatment or clinical trials, and 50 percent for
research described in such clause that does in-
volve treatment and clinical trials.
‘‘(iii) In expending the amounts appro-
priated under clause (i) for a fiscal year, the
Director of the Institute shall give priority to
the following activities regarding ovarian can-
cer:
‘‘(I) Developing a test for the early
detection of the cancer.
‘‘(II) Research to identify precursor
lesions and research to determine the man-
ner in which benign conditions progress to
malignant status.
‘‘(III) Research to determine the rela-
tionship between the cancer and endo-
metriosis.
‘‘(IV) Ensuring that, in clinical re-
search on the cancer that is conducted or
supported by the Institute, appropriate
counseling is provided to women before the
women participate as subjects in the re-
search, including (subject to changes in the
applicable facts) informing women that
there may be a genetic basis to such can-
cer.’’.
SEC. 3. PUBLIC INFORMATION AND EDUCATION ON OVAR-
IAN CANCER.
Section 417(d)(4) of the Public Health Service Act
is amended by striking ‘‘section 413; and’’ and inserting
the following: ‘‘section 413, which programs shall include
programs on ovarian cancer that (subject to changes in
the applicable facts) provide information and education
regarding—
‘‘(A) screening procedures for such cancer,
including the fact that there is not a procedure
that reliably provides for the early detection of
such cancer;
‘‘(B) the fact that there may be a genetic
basis to such cancer;
‘‘(C) factors indicating a substantial risk
of such cancer; and
‘‘(D) the various treatments for such can-
cer and the extent to which the treatments are
effective; and’’.
SEC. 4. MEMBERSHIP OF NATIONAL CANCER ADVISORY
BOARD.
The membership of the National Cancer Advisory
Board under section 406(h)(2) of the Public Health Serv-
ice Act shall include one or more individuals who are at
high risk for developing ovarian cancer.
SEC. 5. EFFECTIVE DATE.
This Act takes effect October 1, 2001, or upon the
date of the enactment of this Act, whichever occurs later.
Æ